FR167653 ameliorates ischemia-reperfusion injury of the rat liver through P38 mitogen-activated protein kinase pathway.
Kobayashi
M
M
Second Department of Surgery, Gunma University School of Medicine, Maebashi, Japan.
Takeyoshi
I
I
Yoshinari
D
D
Koibuchi
Y
Y
Koyama
T
T
Kawashima
Y
Y
Ohwada
S
S
Matsumoto
K
K
Morishita
Y
Y
D000818:Animals; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007375:Interleukin-1 / Q000378:metabolism; D008099:Liver / Q000098:blood supply*; D008297:Male; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism*; D011720:Pyrazoles / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012039:Regional Blood Flow; D015427:Reperfusion Injury / Q000097:blood / Q000517:prevention & control*; D015398:Signal Transduction; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism; D048051:p38 Mitogen-Activated Protein Kinases
C104334:FR 167653; D007166:Immunosuppressive Agents; D007375:Interleukin-1; D011720:Pyrazoles; D011725:Pyridines; D014409:Tumor Necrosis Factor-alpha; D020928:Mitogen-Activated Protein Kinases; D048051:p38 Mitogen-Activated Protein Kinases